Identification of a protein signature in renal allograft rejection

Serum creatinine functions as a poor surrogate marker of renal allograft dysfunction and long‐term graft survival. By measuring multiple proteins simultaneously in the serum of transplant patients, we can identify unique protein signatures of graft dysfunction.

[1]  J. Schold,et al.  Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  I. Roberti,et al.  SERIAL EVALUATION OF CELL SURFACE MARKERS FOR IMMUNE ACTIVATION AFTER ACUTE RENAL ALLOGRAFT REJECTION BY URINE FLOW CYTOMETRY: Correlation with Clinical Outcome1 , 2001, Transplantation.

[3]  Mee Young Park,et al.  L1‐regularization path algorithm for generalized linear models , 2007 .

[4]  A. Butte,et al.  Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. , 2009, Kidney international.

[5]  M. A. Yousuf,et al.  Heat shock protein 27 mediated signaling in viral infection. , 2012, Biochemistry.

[6]  A. Burch,et al.  Modification and Reorganization of the Cytoprotective Cellular Chaperone Hsp27 during Herpes Simplex Virus Type 1 Infection , 2009, Journal of Virology.

[7]  M. Sarwal,et al.  Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. , 2010, Journal of the American Society of Nephrology : JASN.

[8]  Kevin K. Anderson,et al.  ProMAT: protein microarray analysis tool , 2006, Bioinform..

[9]  S. Khoury,et al.  Assessment by flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipients , 2004, Clinical transplantation.

[10]  Arul M Chinnaiyan,et al.  Development of an Internally Controlled Antibody Microarray* , 2005, Molecular & Cellular Proteomics.

[11]  W. Payne,et al.  THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG‐TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2 , 1994, Transplantation.

[12]  P. Nickerson,et al.  Urinary CXCL9 and CXCL10 Levels Correlate with the Extent of Subclinical Tubulitis , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  H. Bang,et al.  Validation of Noninvasive Diagnosis of BK Virus Nephropathy and Identification of Prognostic Biomarkers , 2010, Transplantation.

[14]  S. Kalko,et al.  Urine proteomics to detect biomarkers for chronic allograft dysfunction. , 2009, Journal of the American Society of Nephrology : JASN.

[15]  J. Lindon,et al.  NMR spectroscopy as a novel approach to the monitoring of renal transplant function. , 1993, Kidney international.

[16]  B. Kasiske,et al.  Chronic allograft nephropathy , 2008, Current opinion in nephrology and hypertension.

[17]  V. Sharma,et al.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients. , 2005, The New England journal of medicine.

[18]  P. Nickerson,et al.  Detection of Subclinical Tubular Injury After Renal Transplantation: Comparison of Urine Protein Analysis With Allograft Histopathology , 2007, Transplantation.

[19]  R. Mannon,et al.  Connective Tissue Growth Factor is a Biomarker and Mediator of Kidney Allograft Fibrosis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  M. Suthanthiran,et al.  Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. , 2001, The New England journal of medicine.

[21]  M. Sarwal,et al.  Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. , 2003, The New England journal of medicine.

[22]  J. Pickering,et al.  Urinary Soluble HLA-DR Is a Potential Biomarker for Acute Renal Transplant Rejection , 2010, Transplantation.

[23]  S. McClintock,et al.  Screening of serum samples from Wegener's granulomatosis patients using antibody microarrays , 2007, Proteomics. Clinical applications.

[24]  R. Fisher,et al.  Establishing the Molecular Pathways Involved in Chronic Allograft Nephropathy for Testing New Noninvasive Diagnostic Markers , 2007, Transplantation.

[25]  H. Meier‐Kriesche,et al.  Poor Predictive Value of Serum Creatinine for Renal Allograft Loss , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  M. C. V. D. Heuvel,et al.  Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease , 2007, The Journal of pathology.

[27]  V. Sharma,et al.  Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. , 2004, Kidney international.

[28]  C. Newstead,et al.  Soluble CD30 as a prognostic factor for outcome following renal transplantation , 2009, Journal of Clinical Pathology.